Towards cervical cancer elimination: DNA methylation as a triage strategy
Today we discuss with Professor Gloria I. Sanchez her latest research into DNA methylation as a triage strategy for women testing HPV positive at the […]
cervix
Finding the optimal HPV test for primary screening and triage in Latin America
In this blog, we speak to Dr Maribel Almonte Pacheco, Prevention and Implementation Group Head at IARC. Dr Almonte is the chief investigator on the […]
Over 99.5% of young women survive following a diagnosis of IA cervical cancer
The earliest stage of cervical cancer (known as micro-invasive or stage IA) is treated with minimally-invasive fertility-preserving surgery, often as an outpatient. In fact, very […]
From theory to practice: HPV testing in cervical screening really does work!
After months of eager anticipation, the results from the English HPV implementation pilot have been published. Compared to current screening HPV testing detected 50% more […]
To tell or not to tell – what should we do?
The clinical director of the Irish national cervical screening programme Ireland, Dr Grainne Flannelly, resigned at the end of April. It was revealed that she […]
Is it safe to export cancer screening?
A woman in the Republic of Ireland, Vicky Phelan, recently settled with a laboratory in America receiving $2.5million compensation for them missing abnormalities on her […]